Apex1 Identified as Key Driver in Bone Fracture Repair

A recent study has pinpointed apurinic/apyrimidinic endonuclease 1 (Apex1) as a redox-regulated driver of bone fracture repair. While bone fractures generally heal efficiently, a significant number of patients face nonunion, a condition causing chronic pain and prolonged disability. This research, published on January 16, 2026, in Volume 14 of the journal Bone Research, delves into the molecular mechanisms critical for initiating successful bone repair.

Apex1 is crucial for both the initial inflammatory phase and the subsequent reparative phase of bone fracture healing.

Unraveling Apex1's Role in Healing

Led by Dr. Emma Muiños-López, the research team employed genetically engineered mouse models to selectively silence Apex1 in mesenchymal progenitor cells. The study unequivocally demonstrated Apex1's vital role across two distinct phases of fracture repair:

• Initial Inflammatory Phase: Apex1 is indispensable for activating Bmp2, a master regulatory gene that initiates healing by stimulating periosteal expansion and callus formation. The absence of Apex1 resulted in diminished Bmp2 expression and consequently delayed early fracture healing.

• Reparative Phase: Apex1 is also critical for the maturation of chondrocytes and their eventual replacement by bone through endochondral ossification. In Apex1-deficient mice, chondrocytes failed to progress adequately, impairing vascular invasion and subsequent bone formation, leading to nonunion-like healing defects.

Promising Therapeutic Avenues

Intriguingly, the study revealed that healing defects stemming from Apex1 deficiency could be successfully reversed by restoring Bmp2 signaling. This was achieved either through genetic overexpression or localized delivery of recombinant Bmp-2. This intervention effectively rescued callus formation and significantly improved fracture repair, confirming that Apex1's function operates upstream of Bmp2.

These groundbreaking findings underscore the potential of redox-modulating strategies as a novel approach to enhance bone repair. Such strategies could particularly benefit patients at high risk of nonunion, including older adults, smokers, and individuals with diabetes.